Events
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer without cancer progression
- ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow breast cancers, avoid misclassification
- Global warming may raise women’s cancer risk
- ESMO Breast 2025: Immunotherapy research shows promising results for patients with advanced HER2-positive breast cancer
Lower screening age calls for more tailored bowel cancer surveillance
- Colon cancer rates are rising among young people – could changes to children’s gut bacteria explain why?
- AACR 2025: A liquid biopsy-based assay could detect recurrence prior to imaging in patients with resectable colorectal cancer
- Cell-free DNA testing: a promising future for colorectal cancer screening?
Cancer groundshot: Access to proven treatments must parallel development of new therapies
Bishal Gyawali, Queen’s University, Ontario Where should investment be made today in order to save the maximum number of lives…








